Neolife SA (ALNLF) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Neolife SA stock €0.08, price €0.05, upside +63.4%, quality 55 out of 100. Rating: strongly undervalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range €0.0216 – €0.4370 · fair‑value band €0.0629 – €0.1118 · the €0.0518 price screens below the €0.0846 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Neolife in your weekly email
Every Wednesday you see whether Neolife is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Neolife SA manufactures and sells construction materials. The company offers cladding panels, decorative profiles, molding, and decking boards. It also provides BimObject for designing and modelling BIM projects. The company was incorporated in 2012 and is based in Champagne-Au-Mont-D'Or, France.
Stock analysis
Neolife SA (ALNLF) currently trades at €0.0518, while our model-based Fair Value estimate is €0.0846, implying the stock looks roughly 39% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of €0.1150 per share, and 6 of the 7 models we run sit above the €0.0518 price.
Bear case: the Asset-Based group reads lowest at €0.0100, and 1 of the 7 models stay below the price. Data coverage for this calculation is low.
Scenario range: €0.0629 (bear) to €0.1118 (bull), the price of €0.0518 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Consumer Cyclical sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Neolife SA reported revenue of €12.4M in FY2025 versus €10.7M in FY2021, a compound +3.8%/yr. Reported net income was −€117K in FY2025.
Key figures
Market cap €5.0M Micro · P/S ratio 0.46 · Net margin −0.9% · Return on equity 1,042% · Return on assets (EBIT) −4.6% (5-year average) · Operating margin 1.2% · Revenue (TTM) €12.4M · Revenue growth (YoY) +10.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (low confidence).
What moves the price
The share trades about 41% below its 52-week high and 44% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −24% fair-value upside, at 63%, ALNLF screens cheaper than that median.
Fair Value models
Bear€0.0629Fair Value €0.0846Bull€0.1118
Price €0.0518 · Upside +63.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+2.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.7%
Start year 2020 (pandemic). Over 10 years: +12.6% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−4.4% (2020) → −6.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−9.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −11.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Furnishings, Fixtures & Appliances · 297 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Neolife SA Fair Value". https://www.fairvalue-calculator.com/stock/ALNLF
Frequently asked questions
Is Neolife SA (ALNLF) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of €0.0846 versus a price of €0.0518, about +63% upside (undervalued).
What is the fair value of ALNLF?
Our model-based fair value for Neolife SA is €0.0846 (as of Nov 7, 2026), built from audited fundamentals. The current price: €0.0518.
What is the quality score of ALNLF?
Neolife SA has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Neolife SA (ALNLF)?
Our model-based price target is the fair value of €0.0846 (as of Nov 7, 2026) from 7 valuation models. Cautious scenario €0.0629, optimistic scenario €0.1118. It is a calculation from audited fundamentals, not an analyst target.
What is the Neolife SA stock forecast for 2026?
Our models put fair value at €0.0846, about +63% upside versus a price of €0.0518 (undervalued). Cautious scenario €0.0629, optimistic scenario €0.1118. The calculation is refreshed regularly with new filings.
What is the revenue of Neolife SA (ALNLF)?
Neolife SA reported trailing-twelve-month revenue of about €12.4M (latest available figure, as of Nov 7, 2026).
What growth is priced into Neolife SA (ALNLF)?
For today's price to be fair in a discounted-cash-flow model, Neolife SA would have to grow free cash flow by -9.1 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.7 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of ALNLF use?
Our models discount Neolife SA at 9.8 %: a base by market capitalisation (nano), damped by beta 0.82, country premium for France. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Neolife SA that is -9.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has Neolife SA (ALNLF) delivered so far?
Over the past 5 years revenue at Neolife SA grew +9.7 % a year. The price currently implies free-cash-flow growth of -9.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Neolife SA (ALNLF) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Neolife SA (-9.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Neolife SA (ALNLF)?
The free-cash-flow yield on the price is 12.12 %: that much free cash flow Neolife SA produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Neolife SA (ALNLF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Neolife SA it is €0.0846 per share (as of Nov 7, 2026), against a price of €0.0518. It is the blended result of 7 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Neolife SA stock overvalued or undervalued in 2026?
As of Nov 7, 2026, ALNLF trades below its calculated fair value: price €0.0518, fair value €0.0846, a gap of about +63% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALNLF?
No. The price is what the market pays today (€0.0518); the fair value is what the company's own numbers justify (€0.0846). For Neolife SA the two are €0.0328 per share apart. That gap is exactly why we show both numbers side by side.
How much is Neolife SA worth?
The market values Neolife SA at about €5.0M (market capitalisation, as of Nov 7, 2026). Per share that is €0.0518; our models calculate a fair value of €0.0846 per share.
What do the bullish and bearish scenarios say about ALNLF?
Our models span a range for Neolife SA: cautious scenario €0.0629, base €0.0846, optimistic €0.1118 per share (as of Nov 7, 2026, price €0.0518). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Neolife SA (ALNLF)?
Balance-sheet figures for Neolife SA (as of Nov 7, 2026): debt of 0.05 per unit of equity. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is ALNLF from its 52-week high?
Neolife SA trades at €0.0518, about 41% below its 52-week high of €0.0880 and 44% above the low of €0.0360 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of €0.0846 is for.
Which stocks are comparable to Neolife SA?
From the same area (Consumer Cyclical) we also value Midea Group, Gree Electric Appliances, Inc, SharkNinja, Inc, Haier Smart Home Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Neolife SA stock attractive at the current price?
The data as of Nov 7, 2026: price €0.0518, calculated fair value €0.0846 (+63%), Quality Score 55/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALNLF calculated?
We run Neolife SA through 7 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of €0.0846 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Neolife SA currently trades 39% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Neolife SA (ALNLF)?
The closing price on Nov 9, 2026 was €0.0518. Our model-based fair value is €0.0846, about +63% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Neolife SA right now?
The price is below even our cautious bear case (€0.0629). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Neolife SA
How large is the market capitalisation of Neolife SA (ALNLF)?
The market capitalisation of Neolife SA is €5.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Neolife SA (ALNLF)?
The price-to-sales ratio of Neolife SA is 0.46 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Neolife SA (ALNLF)?
The net margin of Neolife SA is −0.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Neolife SA (ALNLF)?
The return on equity (ROE) of Neolife SA is 1,042% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Neolife SA (ALNLF)?
On an EBIT basis the return on assets of Neolife SA is −4.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Neolife SA (ALNLF)?
The operating margin of Neolife SA is 1.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Neolife SA (ALNLF)?
Revenue at Neolife SA is growing +10.8% versus a year earlier (3y avg −2.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Neolife SA (ALNLF)?
Earnings per share at Neolife SA are growing −65.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Neolife SA (ALNLF) hold?
Neolife SA holds more cash than debt, €294K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Neolife SA in the live analysis
One click puts Neolife SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026